Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PRDS

Pardes Biosciences (PRDS) Stock Price, News & Analysis

Pardes Biosciences logo

About Pardes Biosciences Stock (NASDAQ:PRDS)

Advanced Chart

Key Stats

Today's Range
$2.16
$2.16
50-Day Range
$2.13
$2.16
52-Week Range
$0.75
$3.93
Volume
400 shs
Average Volume
359,530 shs
Market Capitalization
$133.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PRDS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pardes Biosciences and its competitors with MarketBeat's FREE daily newsletter.

PRDS Stock News Headlines

Pardes Biosciences Announces Closing of Tender Offer
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
See More Headlines

PRDS Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Pardes Biosciences investors own include Meta Platforms (META), Valneva (VALN), Arcturus Therapeutics (ARCT), Apellis Pharmaceuticals (APLS), Annexon (ANNX), ANI Pharmaceuticals (ANIP) and AnaptysBio (ANAB).

Company Calendar

Today
7/15/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:PRDS
CIK
1822711
Fax
N/A
Employees
57
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.29)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$96.63 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-43.36%
Return on Assets
-40.71%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
81.72
Quick Ratio
81.72

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.51 per share
Price / Book
0.86

Miscellaneous

Outstanding Shares
62,012,000
Free Float
36,711,000
Market Cap
$133.95 million
Optionable
Not Optionable
Beta
0.42
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:PRDS) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners